Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2-Indigenous Microbiota Nexus: Does Gut Microbiota Contribute to Inflammation and Disease Severity in COVID-19?
Indranil Chattopadhyay, Esaki M. Shankar
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

Evidences and perspectives of the use of probiotics, prebiotics, synbiotics, and postbiotics as adjuvants for prevention and treatment of COVID-19: A bibliometric analysis and systematic review
Douglas Xavier-Santos, Marina Padilha, Giovanna Alexandre Fabiano, et al.
Trends in Food Science & Technology (2022) Vol. 120, pp. 174-192
Open Access | Times Cited: 97
Diagnostic, Prognostic, and Therapeutic Roles of Gut Microbiota in COVID-19: A Comprehensive Systematic Review
Yeganeh Farsi, Azin Tahvildari, Mahta Arbabi, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 60
Dysbiosis of Oral and Gut Microbiomes in SARS-CoV-2 Infected Patients in Bangladesh: Elucidating the Role of Opportunistic Gut Microbes
S. M. Rafiqul Islam, Md Javed Foysal, M. Nazmul Hoque, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 52
Involvement of the Liver in COVID-19: A Systematic Review
Jayani Kariyawasam, Umesh Jayarajah, Visula Abeysuriya, et al.
American Journal of Tropical Medicine and Hygiene (2022) Vol. 106, Iss. 4, pp. 1026-1041
Open Access | Times Cited: 38
The gut microbiome as a biomarker of differential susceptibility to SARS-CoV-2
Amar Sarkar, Siobhán Harty, Andrew H. Moeller, et al.
Trends in Molecular Medicine (2021) Vol. 27, Iss. 12, pp. 1115-1134
Open Access | Times Cited: 50
Detection of Intestinal Dysbiosis in Post-COVID-19 Patients One to Eight Months after Acute Disease Resolution
Alexandre Soares Ferreira-Junior, Taís Fernanda Borgonovi, Larissa Vedovato Vilela de Salis, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 16, pp. 10189-10189
Open Access | Times Cited: 29
The effect of synbiotic adjunct therapy on clinical and paraclinical outcomes in hospitalized COVID‐19 patients: A randomized placebo‐controlled trial
Mahsa Vaezi, Sahar Ravanshad, Mina Akbari Rad, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 2
Closed Access | Times Cited: 16
The Role of Dysbiosis in Critically Ill Patients With COVID-19 and Acute Respiratory Distress Syndrome
Denise Battaglini, Chiara Robba, Andrea Fedele, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 34
Clostridium butyricum-induced ω-3 fatty acid 18-HEPE elicits anti-influenza virus pneumonia effects through interferon-λ upregulation
Mao Hagihara, Makoto Yamashita, Tadashi Ariyoshi, et al.
Cell Reports (2022) Vol. 41, Iss. 11, pp. 111755-111755
Open Access | Times Cited: 27
Altered gut microbiota patterns in COVID-19: Markers for inflammation and disease severity
Chiranjib Chakraborty, Ashish Ranjan Sharma, Manojit Bhattacharya, et al.
World Journal of Gastroenterology (2022) Vol. 28, Iss. 25, pp. 2802-2822
Open Access | Times Cited: 25
Associations of Nutritional Behavior and Gut Microbiota with the Risk of COVID-19 in Healthy Young Adults in Poland
Paweł Jagielski, Edyta Łuszczki, Dominika Wnęk, et al.
Nutrients (2022) Vol. 14, Iss. 2, pp. 350-350
Open Access | Times Cited: 20
How Does COVID-19 Pandemic Impact on Incidence of Clostridioides difficile Infection and Exacerbation of Its Gastrointestinal Symptoms?
Masoumeh Azimirad, Maryam Noori, Hamideh Raeisi, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 25
Patient Nutrition and Probiotic Therapy in COVID-19: What Do We Know in 2021?
Viktoria Hawryłkowicz, Danuta Lietz‐Kijak, Karolina Kaźmierczak-Siedlecka, et al.
Nutrients (2021) Vol. 13, Iss. 10, pp. 3385-3385
Open Access | Times Cited: 23
Herbal medications and natural products for patients with covid-19 and diabetes mellitus: Potentials and challenges
Abdurrahman Pharmacy Yusuf, Jianye Zhang, Jingquan Li, et al.
Phytomedicine Plus (2022) Vol. 2, Iss. 3, pp. 100280-100280
Open Access | Times Cited: 17
Retracted: Gut microbiota and COVID‐19: A systematic review
SeyedAhmad SeyedAlinaghi, Arian Afzalian, Zahra Pashaei, et al.
Health Science Reports (2023) Vol. 6, Iss. 2
Open Access | Times Cited: 9
The Promising Role of Microbiome Therapy on Biomarkers of Inflammation and Oxidative Stress in Type 2 Diabetes: A Systematic and Narrative Review
Pradipta Paul, Ridhima Kaul, Basma Abdellatif, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 15
Renal Health Improvement in Diabetes through Microbiome Modulation of the Gut–Kidney Axis with Biotics: A Systematic and Narrative Review of Randomized Controlled Trials
Pradipta Paul, Ridhima Kaul, Ali Châari
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14838-14838
Open Access | Times Cited: 15
Gut and airway microbiota and their role in COVID-19 infection and pathogenesis: a scoping review
Tik Fung Dave Liu, Elena Philippou, Ourania Kolokotroni, et al.
Infection (2021) Vol. 50, Iss. 4, pp. 815-847
Open Access | Times Cited: 17
Impact of COVID-19 on the Intestinal Microbiome
Carla Venegas‐Borsellino, Senthilkumar Sankararaman, Keelin F. Roche, et al.
Current Nutrition Reports (2021) Vol. 10, Iss. 4, pp. 300-306
Open Access | Times Cited: 17
Precision Postbiotics and Mental Health: the Management of Post-COVID-19 Complications
Muskan Pandey, Archana Bhati, K.G.G.L Shiva Priya, et al.
Probiotics and Antimicrobial Proteins (2021) Vol. 14, Iss. 3, pp. 426-448
Open Access | Times Cited: 16
Gut bacteria, bacteriophages, and probiotics: Tripartite mutualism to quench the SARS-CoV2 storm
Tahereh Zeinali, Niloofar Faraji, Farahnaz Joukar, et al.
Microbial Pathogenesis (2022) Vol. 170, pp. 105704-105704
Open Access | Times Cited: 11
Modulation of gut microbiota as a potential therapy to manipulate drug-induced hepatic damage in COVID-19 patients
Khansa Ahsan, Munir Ahmad Anwar, Nayla Munawar
World Journal of Gastroenterology (2023) Vol. 29, Iss. 11, pp. 1708-1720
Open Access | Times Cited: 6
In the SARS-CoV-2 Pandora Pandemic: Can the Stance of Premorbid Intestinal Innate Immune System as Measured by Fecal Adnab-9 Binding of p87:Blood Ferritin, Yielding the FERAD Ratio, Predict COVID-19 Susceptibility and Survival in a Prospective Population Database?
Martin Tobi, Martin H. Bluth, Noreen F. Rossi, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7536-7536
Open Access | Times Cited: 6
SARS-CoV-2 induced liver injury: Incidence, risk factors, impact on COVID-19 severity and prognosis in different population groups
George D. Liatsos
World Journal of Gastroenterology (2023) Vol. 29, Iss. 16, pp. 2397-2432
Open Access | Times Cited: 5
Epidemiology of Gram-negative bacteria during coronavirus disease 2019. What is the real pandemic?
Adrian Brink, Guy A. Richards, Hafsah Deepa Tootla, et al.
Current Opinion in Infectious Diseases (2022) Vol. 35, Iss. 6, pp. 595-604
Closed Access | Times Cited: 8
Page 1 - Next Page

Scroll to top